NASDAQ · Medical - Instruments & Supplies
ZTEK (ZTEK) Stock
$0.58
+1.71%
NASDAQ: ZTEK
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Zentek Engages IMPAQ Capital Inc. to Broaden Investor Awareness Across North America
TMX Newsfile · Jul 20, 2026
Zentek Engages Atrium Research Corporation For Company-Sponsored Research Coverage
TMX Newsfile · Jul 15, 2026
Zentek's ZenGUARD Enhanced Air Filtration Media Completes Qualification Program With Quality Filters
MT Newswires · Jul 7, 2026
Zentek's ZenGUARD(TM) Enhanced Air Filtration Media Completes Qualification Program with Quality Filters Inc.; First U.S. Commercial Order Received
TMX Newsfile · Jul 7, 2026
Zentek Advances Its Commercialization Strategy in U.S. With ZenGUARD Enhanced Air Filtration Media; Shares Down 7%
MT Newswires · Jun 29, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held1.89%
Institutions Held1.53%
Institutions Float Held1.56%
Peer Comparison
About ZTEK
ZTEK is led by CEO Mohammed Jiwan, employs 24 people, headquartered in CA, publicly traded since 2012.
ZTEK stock trades at $0.58 with a market capitalization of $73.17M. The stock is valued at a price-to-earnings (P/E) ratio of -7.30, price-to-book of 5.26, price-to-sales of 109.50. Over the past 52 weeks the stock has ranged between $0.37 and $1.37, and currently trades 57.7% below its 52-week high.
On profitability, ZTEK generates a return on equity (ROE) of -66.67%, return on capital employed of -71.43%, an operating margin of -1000.00%, a net profit margin of -8.57%.